| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| FATE THERAPEUTICS INC | Director | Stock Option (Right to Buy) | 55K | $109K | $2.73 | May 29, 2025 | Direct |
| FATE THERAPEUTICS INC | Director | Common Stock | 8.67K | $36.7K | $4.23 | Aug 6, 2024 | Direct |
| Akero Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $54.09 | Dec 9, 2025 | Direct |
| Xilio Therapeutics, Inc. | Director | Stock Option (right to buy) | 31K | Jun 11, 2025 | Direct | ||
| Akero Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | Dec 9, 2025 | Direct |